As Canadians contemplated the pending election last week, an important study was published in the science journal Nature Biotechnology. Quietly overlooked, it has the capacity to fundamentally alter how we conduct stem cell research.  Such research has been the subject of much controversy. Embryonic stem cells, some scientists claim, hold the cure for many difficult diseases, like spinal paralysis, Alzheimer’s and Parkinson’s.  Yet creating human life, only to destroy it, even for admirable goals, creates an ethical dilemma. Does this recently published study make that debate a thing of the past?
Embryonic stem cells used for research are obtained through the destruction or cloning of human embryos. The ethical dilemma inspired researchers to find a new way to access the potential of embryonic stem cells without destroying human life. In 2006, two Japanese scientists announced the discovery of a process to do just this—by inserting human genetic material into adult stem cells.  The genetic material reprograms the adult stem cells so that they have the properties of embryonic stem cells. The new stem cells are called induced Pluripotent stem cells (iPS).
The new October 2008 study shows that reprogramming can be accomplished with half the genetic material previously required and an acid to treat the adult stem cells. They write:
Our results raise the question of whether, or how soon, it will be possible to find small molecules to replace OCT 4 and SOX2 [the two human genes inserted] and thereby achieve reprogramming through purely chemical means, making therapeutic use of reprogrammed cells safer and more practical. 
In short, this research opens the way for an eventual method of reprogramming that does not require human material, but rather chemical matter.
The background on stem cell research
Stem cells are like the building blocks of the human body. The Stem Cell Network, an Ottawa-based group that brings stem cell experts together, defines stem cells as those “occur[ing] at the earliest stages of development and provide the starting material for every organ and tissue.” 
In theory, stem cells could be used to repair or rebuild wounded or broken parts of the body—inject them into a severed spinal cord, for example, and they could become spinal cord cells and repair the break. 
There are two forms of stem cells (to simplify some very complex science). Embryonic stem cells come from embryos, the earliest stage of human development.  Adult stem cells, on the other hand, are found in infants, children and adults alike. These cells exist to repair and maintain the human body.
What’s happening in stem cell research today
Currently, stem cell research on human subjects uses adult stem cells. Adult stem cells can be harvested from such things as cord blood, bone marrow and many other human cells. The potential for the rejection of implanted cells is also greatly reduced when a patient’s stem cells are isolated and then reinserted back into their own body.
Still, some maintain that embryonic stem cells are a great hope for cures, and so research on them continues as well. It’s worth noting that the National Institutes of Health, the national medical research agency of the United States government, indicates that no treatments exist as a result of embryonic stem cell research, however, adult stem cell research has already produced successful treatments for human patients. 
Those intimately involved with stem cell research admit there’s an ethical issue at stake. Dr. James Thomson, the first person to isolate human embryonic stem cells, highlighted the difficulties associated with his decision to begin his research. He told the New York Times in 2007 “[i]f human embryonic stem cell research does not make you at least a little bit uncomfortable, you have not thought about it enough.” 
The possible implications
Does the October 2008 study mean choosing between science and ethics on this topic is a thing of the past? Some experts in ethics and biotechnology say the reprogramming research process could eventually mean a safe source of stems cells for research. 
Recent iPS cell research seems in its early stages to provide a positive alternative to embryonic stem cell research. This study points to another avenue for stem cell research, which takes ethical concerns seriously while forging ahead with fruitful scientific endeavours.
Download the full report below